Clinical Trial Update: Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study [Phase 2]

View source ↗

Summary

Phase II open-label study evaluating the efficacy and safety of sintilimab plus bevacizumab in patients with metastatic nasopharyngeal carcinoma after platinum-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Sintilimab (sintilimab)

Snippet

Sponsor: XIANG YANQUN | Conditions: Metastatic Nasopharyngeal Carcinoma, Chemotherapy Effect | Phase 2 | Status: UNKNOWN